about
Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study.Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazoleDual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans.3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstructionKinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study[Drug distribution systems in hospitals]Oral citrulline does not affect whole body protein metabolism in healthy human volunteers: results of a prospective, randomized, double-blind, cross-over studyEffect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over studyWhat do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France
P50
Q33753635-00FF8847-7BDE-4D78-9490-8B7CC4478400Q33946261-97234DC2-21B3-483B-A5A3-A10437AC452BQ34036950-3AD10278-42A5-4D60-B978-891737AE4D76Q36795941-4A0AA2A1-FC9D-477D-81B2-B6B09373EEDCQ39293213-13B782C9-FAAC-4156-B490-F6418D7B78C2Q48634655-FEE4F043-8AA4-467C-8A67-4874743DB0C1Q55021222-EE2E6B7A-2BC3-4CD8-A362-6CBF31D37EDBQ57821882-A26E4C5D-58AE-4762-82F0-61E90B59D6FCQ63977437-4ADC6F12-C6E4-4E17-B8F4-9501E7527AB8Q78490675-1C1CEDF4-E79E-4F5E-A91C-03159B32376EQ84512679-F35AF30C-4BD4-49C2-A42E-C23C5136F7E3Q91043672-54668E88-86A1-4BB4-92BE-296681EFA6F0Q92593049-C2241776-D46B-4173-B62C-51A876CA1D56
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laurent Flet
@ast
Laurent Flet
@en
Laurent Flet
@es
Laurent Flet
@nl
type
label
Laurent Flet
@ast
Laurent Flet
@en
Laurent Flet
@es
Laurent Flet
@nl
prefLabel
Laurent Flet
@ast
Laurent Flet
@en
Laurent Flet
@es
Laurent Flet
@nl
P106
P108
P31
P496
0000-0001-8305-7085